These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22245629)

  • 1. Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pump.
    Bronckers AL; Lyaruu DM; Bervoets TJ; Medina JF; DenBesten P; Richter J; Everts V
    Bone; 2012 Apr; 50(4):901-8. PubMed ID: 22245629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Null mutation of chloride channel 7 (Clcn7) impairs dental root formation but does not affect enamel mineralization.
    Guo J; Bervoets TJ; Henriksen K; Everts V; Bronckers AL
    Cell Tissue Res; 2016 Feb; 363(2):361-70. PubMed ID: 26346547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V-type ATPase proton pump expression during enamel formation.
    Sarkar J; Wen X; Simanian EJ; Paine ML
    Matrix Biol; 2016; 52-54():234-245. PubMed ID: 26586472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The V-ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice.
    Ochotny N; Flenniken AM; Owen C; Voronov I; Zirngibl RA; Osborne LR; Henderson JE; Adamson SL; Rossant J; Manolson MF; Aubin JE
    J Bone Miner Res; 2011 Jul; 26(7):1484-93. PubMed ID: 21305608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
    Wu H; Xu G; Li YP
    J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
    Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
    Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone.
    Smith AN; Jouret F; Bord S; Borthwick KJ; Al-Lamki RS; Wagner CA; Ireland DC; Cormier-Daire V; Frattini A; Villa A; Kornak U; Devuyst O; Karet FE
    J Am Soc Nephrol; 2005 May; 16(5):1245-56. PubMed ID: 15800125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
    Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
    J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of proton pumps in osteoclasts: V-ATPase with a3 and d2 isoforms is a major form in osteoclasts.
    Matsumoto N; Daido S; Sun-Wada GH; Wada Y; Futai M; Nakanishi-Matsui M
    Biochim Biophys Acta; 2014 Jun; 1837(6):744-9. PubMed ID: 24561225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis.
    Zirngibl RA; Wang A; Yao Y; Manolson MF; Krueger J; Dupuis L; Mendoza-Londono R; Voronov I
    J Cell Biochem; 2019 Oct; 120(10):17180-17193. PubMed ID: 31111556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The osteoclast proton pump differs in its pharmacology and catalytic subunits from other vacuolar H(+)-ATPases.
    Chatterjee D; Chakraborty M; Leit M; Neff L; Jamsa-Kellokumpu S; Fuchs R; Bartkiewicz M; Hernando N; Baron R
    J Exp Biol; 1992 Nov; 172():193-204. PubMed ID: 1491225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy.
    Ochotny N; Voronov I; Owen C; Aubin JE; Manolson MF
    J Cell Biochem; 2013 Dec; 114(12):2823-33. PubMed ID: 23908015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. V-ATPases Containing a3 Subunit Play a Direct Role in Enamel Development in Mice.
    Johnson L; Ganss B; Wang A; Zirngibl RA; Johnson DE; Owen C; Bradley G; Voronov I
    J Cell Biochem; 2017 Oct; 118(10):3328-3340. PubMed ID: 28295540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies.
    Mattsson JP; Skyman C; Palokangas H; Väänänen KH; Keeling DJ
    J Bone Miner Res; 1997 May; 12(5):753-60. PubMed ID: 9144341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion transporters in secretory and cyclically modulating ameloblasts: a new hypothesis for cellular control of preeruptive enamel maturation.
    Josephsen K; Takano Y; Frische S; Praetorius J; Nielsen S; Aoba T; Fejerskov O
    Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1299-307. PubMed ID: 20844245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actin binding activity of subunit B of vacuolar H+-ATPase is involved in its targeting to ruffled membranes of osteoclasts.
    Zuo J; Jiang J; Chen SH; Vergara S; Gong Y; Xue J; Huang H; Kaku M; Holliday LS
    J Bone Miner Res; 2006 May; 21(5):714-21. PubMed ID: 16734386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.
    Duan X; Yang S; Zhang L; Yang T
    Theranostics; 2018; 8(19):5379-5399. PubMed ID: 30555553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption.
    Qin A; Cheng TS; Pavlos NJ; Lin Z; Dai KR; Zheng MH
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1422-35. PubMed ID: 22652318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
    Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
    Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.